Bambusa Therapeutics (BBTX) IPO deck
Bambusa Therapeutics is a clinical-stage biopharmaceutical company developing next-generation, long-acting precision bispecific antibodies for immunology and inflammatory disorders.
Bambusa Therapeutics is a clinical-stage biopharmaceutical company developing next-generation, long-acting precision bispecific antibodies for immunology and inflammatory disorders.
%20IPO%20deck){kind=link}